助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[1437]条 当前为第1条到20条[由于搜索限制,当前仅支持显示前5页数据]
 

相关语句
bladder cancer
Study of recombinant human IFN-α-2b bacilli calmette-guerin activated killer cells and against bladder cancer cell in vitro
      
Presently, one of the most potent immunotherapies is the application of bacillus Calmette Guerin (BCG) to prevent recurrences of the superficial bladder cancer.
      
We conclude that the recombinant BCG can activate more PBMCs to anti-bladder cancer in vitro than wild-type BCG does.
      
Radiotherapy is an Effective Treatment for High-Risk T1-Bladder Cancer
      
We have evaluated the efficacy of adjuvant radiotherapy or radiochemotherapy on local control, bladder preservation, recurrence rate and long-term survival after TURB of high-risk T1-bladder cancer.
      
Radiotherapy is an Effective Treatment for High-Risk T1-Bladder Cancer
      
Current Status of Radiation Therapy and Combined-Modality Treatment for Bladder Cancer
      
Organ-Sparing Treatment in Muscle-Invasive Bladder Cancer
      
Combined-Modality Treatment and Organ Preservation in Bladder Cancer
      
Pretreatment Proliferation and Local Control in Bladder Cancer after Radiotherapy with or without Concurrent Chemotherapy
      
Organ-Sparing Treatment of Advanced Bladder Cancer
      
Combined Systemic Therapy and Radiotherapy for Bladder Cancer
      
Bladder wall resection is often required as a treatment for invasive bladder cancer.
      
Construction and expression of a human-mouse chimeric antibody against human bladder cancer
      
Objective: To construct and express a human-mouse chimeric antibody against human bladder cancer.
      
Method: The variable region genes of anti-human bladder cancer monoclonal antibody BDI-1 were cloned by RT-PCR.
      
The chimeric antibody against bladder cancer was expressed and characterized.
      
Conclusion: The constructed chimeric antibody was expressed successfully in eukaryotic cells, and the chimeric antibody had desired affinity against human bladder cancer cells.
      
After transduction and selection, G418-resistant leukemia K562, mammary carcinoma MCF-7, and bladder cancer 5637 cells were developed, in which the integration of both EGFP and neomycin resistance gene was confirmed by DNA amplification.
      
This suggests that hTERT gene might be a suitable gene target for bladder cancer therapy.
      
 

首页上一页12345下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社